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Abstract: Platelets are known to have a role major in the pathogenesis of 
atherothrombosis. More giant and hyperreactive platelets accelerate the formation of 
an intracoronary thrombus. An increased MPV as an indicator of larger and more 
reactive platelets represents a risk factor for overall vascular mortality, including 
myocardial infarction. This study aimed to identify the increase of Mean Platelet 
Volume in Patients with Acute Coronary Syndromes, especially in ST-elevation 
myocardial infarction and Non-ST-elevation myocardial infarction. Thus this parameter 
can be used as consideration for diagnosis and treatment decisions.  This research is 
an analytic observational with a cross-sectional method. The subjects were patients 
with STEMI and NSTEMI who were hospitalized in ICCU Dr.Sardjito Hospital 
Yogyakarta. Thirty-four subjects STEMI and NSTEMI patients at Dr. Sardjito Hospital, 
consisting of 28 males (82,35%) and six women (17,65%) with a mean age of 55,5 ± 
10,3 years. The results showed that MPV in AMI was higher in patients with STEMI 
than NSTEMI, but this difference is not significant (p = 0,091). This study concludes 
that MPV to be higher in patients with STEMI compared to NSTEMI. MPV may be 
used as a marker of myocardial infarction in clinically appropriate situations. 
Keywords: Mean Platelet Volume, Acute Coronary Syndromes, ST-elevation 
myocardial infarction, Non-ST-elevation myocardial infarction 
 
INTRODUCTION 
Cardiovascular disease is a significant public health problem because the 
global number of deaths has increased in the past decade. According to the World 
Health Organization, an estimated 17.9 million people died from CVDs in 2016, 
representing 31% of all global deaths (WHO, 2017). The mortality rate due to 
cardiovascular disease in Indonesia is increasing year by year. It reported that 
Coronary Heart Diseases (CHD) is a significant cause of death in Indonesia by 26.4%, 
four times higher than death by cancer (Indonesian Heart Association, 2019). 
Individuals with comorbidities such as diabetes mellitus, dyslipidemia, or hypertension 
are at risk of developing cardiovascular disease.  
Acute Coronary Syndrome (ACS) is a cardiovascular disease with acute 
manifestations due to coronary atheroma plaque rupture. This disease is related to 
changes in the plaque composition and thinning of the fibrous covering the plaque. 
This event will be followed by the process of platelet aggregation and activation of the 
coagulation pathway to form a platelet-rich thrombus (white thrombus). This thrombus 
will clog the coronary artery holes either in total or partially or become a micro 
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embolism that blocks more distal coronary arteries. The release of vasoactive 
substances also occurs, causing vasoconstriction, thereby aggravating coronary blood 
flow disruption. Decreased coronary blood flow causes myocardial ischemia. Oxygen 
supply that stops for approximately 20 minutes can cause the heart muscle to 
experience necrosis (myocardial infarction). The total occlusion of coronary arteries 
does not always cause myocardial infarction. Subtotal obstruction, accompanied by 
dynamic vasoconstriction, can cause ischemia and necrosis of heart muscle tissue. In 
addition to necrosis, the result of ischemia is impaired myocardial contractility, 
dysrhythmias, and ventricular remodeling (changes in shape, size, and function of the 
ventricles) (Irmalita et al., 2015). 
Acute Coronary Syndrome based on history, physical examination, 
electrocardiogram (ECG) examination, and cardiac biomarker examination is divided 
into three types, namely ST-segment Elevation Myocardial Infarction (STEMI), Non-
ST-segment Elevation Myocardial Infarction (NSTEMI), and Unstable Angina Pectoris 
(UAP) ). STEMI is an indicator of the total occlusion of coronary arteries. This situation 
requires revascularization to restore blood flow and myocardial reperfusion as soon 
as possible, medically using fibrinolytic agents or mechanically with primary 
percutaneous coronary intervention. STEMI is diagnosed if there is a complaint of 
acute angina pectoris accompanied by persistent ST-segment elevation in two 
contiguous leads of the electrocardiogram. NSTEMI and UAP are diagnosed if there 
is a complaint of acute angina pectoris without persistent ST-segment elevation in two 
contiguous leads of the electrocardiogram. ECG records can be in the form of ST-
segment depression, T wave inversions, flat T waves, pseudo-normalization T waves, 
or even unchanged. UAP and NSTEMI are differentiated based on the incidence of 
myocardial infarction, which is characterized by an increase in cardiac biomarkers, 
which commonly used are Troponin I / T or CK-MB. If there is a significant increase in 
the cardiac biomarker examination results, the diagnosis becomes NSTEMI, while the 
UAP does not increase significantly. (Irmalita et al., 2015).  
Platelets have an essential role in the formation of atherosclerotic plaque and 
pathogenesis of atherothrombosis. One of the platelet indices, namely platelet size 
(MPV), is a hemostasis physiological variable. Increased MPV values are used as a 
sign of large and reactive platelets. Large and reactive platelets accelerate the 
formation of thrombus in coronary arteries. Enhanced platelet aggregation is 
associated with unstable angina and myocardial infarction (Mumpuni et al., 2016). 
Platelet size is determined at the level of progenitor cells, namely megakaryocytes. 
Research has reported that cytokines such as interleukin-3 or interleukin-6 can 
influence megakaryocytes to produce larger and reactive platelets. This may illustrate 
the presence of a risk factor for overall vascular mortality, including myocardial 
infarction. Studies have reported that MPV increases before the event of acute 
myocardial infarction. MPV can be detected earlier compared to the specific and non-
specific myocardial infarction markers. MPV examination is a routine hematological 
examination and is available in most clinical laboratories to provide benefits in 
managing myocardial infarction (Manchanda et al., 2015). There are no consistent 
measurements used as a strong predictor of clinical deterioration in ACS. This study 
aims to determine the increase in the Mean Platelet Volume (MPV) in acute myocardial 
infarction patients, especially STEMI and NSTEMI in Dr. Sardjito Hospital Yogyakarta. 
 
MATERIALS AND METHOD 
This study is an observational analytic study with a retrospective design. The 
study was conducted at the Clinical Laboratory Installation Dr. Sardjito Hospital 
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Yogyakarta from April 2014 to August 2014. The research subjects were STEMI and 
NSTEMI patients discharged from the ICCU Dr. Sardjito Hospital Yogyakarta based 
on a history of physical examination and electrocardiogram (ECG) examination. The 
inclusion criteria were: (1) patients with a diagnosis of STEMI or NSTEMI, (2) patients 
with onset ≤ 48 hours, (3) patients aged 30-70 years, and (3) patients who agreed to 
informed consent to participate in this study. Exclusion criteria were: (1) patients with 
stage V chronic renal failure, chronic heart failure with functional class NYHA III and 
above, cirrhosis of the liver, (2) patients with acute stroke, acute infections, sepsis, 
and venous thromboembolism, (3) patients who get intervention of primary 
percutaneous coronary or thrombolysis, and (4) patients suffering from a history of 
malignancy. The Ethical Committee of the Faculty of Medicine, Public Health, and 
Nursing Universitas Gadjah Mada approved this study (number 
KE/FK/0069/EC/2019). 
MPV examination was carried out using venous blood samples with EDTA 
anticoagulant as much as 2 mL and examined using the ADVIA 120 Hematology 
Analyzer. Measurement was carried out immediately after collection, with a maximum 
time of 4 hours after sampling. During this time lag, the sample was placed at room 
temperature of 18oC - 25oC. Subjects were also examined for glucose and lipid 
profiles. 
Data on the characteristics of research subjects is displayed descriptively. 
Characteristics of research subjects presented in the form of mean ± standard 
deviations for normally distributed data and the median (minimum value - maximum 
value) for data that is not normally distributed, while normality tests for continuous data 
using Kolmogorov Smirnov analysis. Mann Whitney U-test was used as the average 
difference test between the two groups. The significance value was considered 
significant if the p-value <0.05. All calculations are done with a computerized system. 
  
RESULTS AND DISCUSSION 
A total of 34 STEMI and NSTEMI patients were obtained from this study with 
characteristics, as shown in Table 1.  
 
Table 1. Basic characteristics of research subjects (n = 34 subjects) 
 
Variable Value  
Age (year)a 55.5 ± 10.3 
Sex (%) 
- Man (28) 




Bodyweight (kg) 63.4 ± 9.3 
Body height (cm) 160.7 ± 7.3 
Platelet (x10^3/µL)b 233 (158-588) 
MPV (fL)a 8.97 ± 1.49 
Glucose ad random (mg/dL)b 144 (87-528) 
Total Cholesterol  (mg/dL)b 181 (104-483) 
Triglyceryde (mg/dL)b 114 (42-312) 
LDL (mg/dL)a 131 ± 34.2 
HDL (mg/dL)b 39 (21-102) 
a Data is normally distributed: mean ± SD 
b Data is not normally distributed: median (minimum-maximum) 
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The participant’s mean age in this study was in the group of high risk category, 
according to the National Cholesterol Education Program (NCEP), which is more than 
45 years for men and more than 55 years for women (Organization, 2016). Based on 
gender, most patients were male. This corresponds to the research by Araújo et al. 
(2018) that gets results from 379 STEMI patients, 278 patients (43%) were male, and 
101 (44.5%) were female, from 494 NSTEMI patients, 368 patients (57%) were male, 
and 126 (55.5%) were female. That study obtained platelet and MPV value were 228.5 
± 59.2 x 103 / µL and 8.9 ± 0.8 fL. The average LDL was 131 ±  34.2 mg / dL, which is 
in the borderline-high classification according to the National Cholesterol Education 
Program (NCEP) (Organization, 2016). The subjects have risk factors on the lipid 
profile. The comparison of Mean Platelet Volume (MPV) based on risk factors for 
myocardial infarction showed in Table 2. 
 
Table 2. Comparison of Mean Platelet Volume (MPV) Based on Risk Factors 





n  Mean ± SD 
Sex Man 28 8.95±1.55 0.957 
 Female 6 8.92±1.22  
Hypertension Yes 19 8.48±1.50 0.038* 
 No 15 9.53±1.26  
Diabetes Mellitus Yes 10 8.66±1.50 0.474 
 No 24 9.07±1.48  
Dyslipidemia Yes 4 8.87±1.40 0.919 
 No 11 8.96±1.51  
Smoking Yes 15 9.09±1.46 0.632 
 No 19 8.84±1.52  
Myocardial Infarct STEMI 17 9.38±1.51 0.091 
 NSTEMI 17 8.52±1.36  
         Student T test; * Statistically significant (p <0.05) 
 
Differences in the mean of MPV by sex were found to be insignificant (p= 
0.957). This correspond to other study7 which found no association between sex and 
MPV value (p = 0.887). MPV values on patients with hypertension risk factor were 
higher than without hypertension (p = 0.038). Other studies also showed that MPV 
values were higher in patients with hypertension (Raiet al., 2016; Surgit et al., 2015). 
Agrawal et al. (2016) reported differences in the mean of MPV based on diabetes 
mellitus risk factor. However, this is different from the findings in the current study. 
Diabetes, due to a lack of insulin or insulin resistance, is considered a thrombotic state 
and can increase platelets activity. The mean of MPV was found to be higher in the 
patient without dyslipidemia compared to patients with dyslipidemia, but the difference 
was not statistically significant (p = 0.919). This is not following the study by Rai et al. 
(2016), which found the mean of MPV was higher in patients with dyslipidemia. The 
MPV in smokers was higher than in non-smokers but was insignificant (p = 0.632). 
Hypertension can damage the arteries, thus hardening and narrowing. In 
contrast, in dyslipidemia, there is a buildup of fat that can reduce the arteries' diameter, 
causing occlusion of the blood vessels. People with diabetes with excess blood 
glucose also have a risk of myocardial infarction. Glucose in the blood can damage 
the endothelium of blood vessels, an inflammatory reaction occurs (deposition of 
P a g e  | 149 
 
Copyright © 2020, MLTJ, ISSN 2461-0879 
 
platelets, macrophages, and fibrous tissue), causing thickening of blood vessels. 
Narrowing or occlusion of the coronary arteries can lead to ischemia and myocardial 
infarction. (3) Depression is also a risk factor for coronary heart disease. The 
mechanism of increased MPV in diabetes mellitus patients is still unclear. It said that 
hyperglycemia increases the production of thrombopoietin. IL-6 is also associated with 
insulin resistance in diabetes mellitus patients, so that IL-6 and thrombopoietin 
regulation influenced by diabetic conditions, such as hyperglycemia and 
hyperinsulinemia, which can increase platelet size.  
In this study, MPV mean differences were higher in patients without risk factors 
for hypertension, diabetes mellitus, and dyslipidemia but were not statistically 
significant. These results differ from some studies, where MPV correlates with these 
risk factors (Ji et al., 2019; Inoue et al., 2020). Results that are not the same as other 
studies could be due to an insufficient number of subjects. We also did not analyze 
the level of depression in subjects, which may increase MPV. The depression status 
is associated with a high MPV level. MPV and depressants were found to have an 
independent association known to influence platelet activity (Bondade et al., 2018). 
Serotonin (5-hydroxytryptamine, or 5-HT) plays an important role in depression and 
more than 99% of the body's serotonin stored in platelets. Selective Serotonin 
Reuptake Inhibitors (SSRIs) are the most widely used class of antidepressants to treat 
depression. Platelets have biochemical similarities with central serotonergic neurons 
in the absorption, storage, and metabolism of serotonin. This has been used as a 
model to study the central nervous serotonin system's uptake and release. Serotonin 
is a relatively weak platelet agonist but can have potential in the process of platelet 
aggregation. Serotonin metabolism abnormalities can cause interference with the 
suppression of depression and abnormal platelets (Dietrich-Muszalska et al., 2016). 
The MPV values in STEMI and NSTEMI patients in this study were 9.38 ± 1.51 
and 8.52 ± 1.36, respectively. Based on MPV reference values of 7.11 - 9.11 fL for the 
Advia 120 Hematology System, it found that the MPV value in STEMI patients was 
higher than the reference value, whereas, in NSTEMI patients, the MPV value was still 
in the normal range (LabPharm et al., 2016). The difference in the mean of MPV in 
acute myocardial infarct patients showed that MPV was higher in patients with STEMI 
than NSTEMI, but it was not significant (p = 0.091). Thygesen et al. (2018) described 
that infarction is caused by coronary atherosclerosis and thrombus formation. 
Thrombocytes play an essential role in atherosclerosis and thrombosis. The ruptured 
or discharged atherosclerosis plaque will recruits thrombocyte to endothelial. The 
clogged blood vessels become entirely obstructed with newly formed thrombosis. 
Larger platelets have more potential for pro-thrombotic. Increased platelet volume is 
more reactive, with more advanced thromboxane A2 and serotonin (Ji et al., 2019).  
 If the research is carried out on more subjects, the MPV value's statistical 
significance will likely found in both conditions. MPV can be an additional diagnostic 
parameter in ACS diagnosis, but it is necessary to set a cut off value. 
 
CONCLUSION 
 From the results of this study, it found that the average MPV in acute myocardial 
infarct patients showed that MPV was higher in STEMI compared to NSTEMI patients.  
MPV is a routine and direct laboratory measurement in most clinical laboratories to be 
used as an additional laboratory parameter of myocardial infarction in appropriate 
clinical situations. Further studies can be performed in a more robust group of patients 
with acute myocardial infarct and compared with healthy controls to confirm their use 
as additional parameter for diagnosis. 
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